Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag135 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Mao Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Department of Biomedicine, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland. Hauptthemen laut MEDLINE: RGS Proteins, Colitis, Inflammatory Bowel Diseases. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SNSF.
Abstract (Originalsprache)
Regulators of G protein signaling (RGS) deactivate G proteins associated with G protein-coupled receptors (GPCRs), a large receptor family with diverse functions. Of the 20 RGS, the Rgs14 single-nucleotide polymorphism is associated with inflammatory bowel disease, and Rgs14 expression is higher in macrophages than in epithelial cells. This manuscript describes a novel conditional mouse line that enables deletion of Rgs14 in macrophages and intestinal epithelial cells. We demonstrate that Rgs14 deletion in macrophages increases their reactive oxygen species production and their ability to induce T cell proliferation. The deletion in macrophages, but not in epithelial cells, exacerbates colitis severity. This novel conditional mouse model will facilitate further investigation of Rgs14 in inflammatory bowel disease and potentially in other areas, including metabolism, neuroscience, and aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology, Department of Biomedicine, University of Basel, Hebelstrasse 20, Basel 4031, Switzerland.
- Department of Gastroenterology and Hepatology, University Digestive Health Care Center Clarunis, Basel 4002, Switzerland.
Förderung
- SNSF
Zitieren
APA
Chen, M., Melhem, H., & Niess, J. H. (2026). Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag135
Vancouver
Chen M, Melhem H, Niess JH. Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag135
BibTeX
@article{Chen2026,
author = {Chen, Mao and Melhem, Hassan and Niess, Jan Hendrik},
title = {Genetic deletion of the inflammatory bowel disease-associated risk gene Rgs14 aggravates experimental colitis},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag135}
}
EUVIMED